Structure

Physi-Chem Properties

Molecular Weight:  434.14
Volume:  427.421
LogP:  5.981
LogD:  3.742
LogS:  -3.421
# Rotatable Bonds:  0
TPSA:  109.36
# H-Bond Aceptor:  7
# H-Bond Donor:  3
# Rings:  6
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.475
Synthetic Accessibility Score:  4.116
Fsp3:  0.32
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.054
MDCK Permeability:  1.6099074855446815e-05
Pgp-inhibitor:  0.658
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.297
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.008

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.006
Plasma Protein Binding (PPB):  99.83378601074219%
Volume Distribution (VD):  0.388
Pgp-substrate:  1.9570671319961548%

ADMET: Metabolism

CYP1A2-inhibitor:  0.431
CYP1A2-substrate:  0.51
CYP2C19-inhibitor:  0.201
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.816
CYP2C9-substrate:  0.863
CYP2D6-inhibitor:  0.161
CYP2D6-substrate:  0.154
CYP3A4-inhibitor:  0.183
CYP3A4-substrate:  0.158

ADMET: Excretion

Clearance (CL):  1.725
Half-life (T1/2):  0.157

ADMET: Toxicity

hERG Blockers:  0.006
Human Hepatotoxicity (H-HT):  0.947
Drug-inuced Liver Injury (DILI):  0.979
AMES Toxicity:  0.449
Rat Oral Acute Toxicity:  0.932
Maximum Recommended Daily Dose:  0.922
Skin Sensitization:  0.169
Carcinogencity:  0.806
Eye Corrosion:  0.003
Eye Irritation:  0.196
Respiratory Toxicity:  0.595

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475805

Natural Product ID:  NPC475805
Common Name*:   Cycloartobiloxanthone
IUPAC Name:   n.a.
Synonyms:   Cycloartobiloxanthone
Standard InCHIKey:  OCZFLOUWXXGBPC-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C25H22O7/c1-24(2)6-5-10-16(31-24)9-14(27)19-20(29)11-7-12-17-18(22(11)30-21(10)19)13(26)8-15(28)23(17)32-25(12,3)4/h5-6,8-9,12,26-28H,7H2,1-4H3
SMILES:  Oc1cc(O)c2c3c1c1oc4c5C=CC(Oc5cc(c4c(=O)c1CC3C(O2)(C)C)O)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL516519
PubChem CID:   10342859
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones
                • [CHEMONTID:0003521] Pyranoxanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32569 artocarpus rigida Species Moraceae Eukaryota n.a. n.a. n.a. PMID[20384315]
NPO32569 artocarpus rigida Species Moraceae Eukaryota Stems n.a. n.a. PMID[29227656]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 = 7.2 ug ml-1 PMID[567374]
NPT83 Cell Line MCF7 Homo sapiens ED50 = 7.7 ug ml-1 PMID[567374]
NPT163 Individual Protein Nuclear factor NF-kappa-B p105 subunit Homo sapiens IC50 > 10000.0 nM PMID[567375]
NPT139 Cell Line HT-29 Homo sapiens ED50 = 3.7 nM PMID[567375]
NPT721 Individual Protein Nuclear factor NF-kappa-B p65 subunit Homo sapiens IC50 > 10000.0 nM PMID[567375]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475805 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9937 High Similarity NPC101107
0.975 High Similarity NPC476637
0.9688 High Similarity NPC126204
0.9686 High Similarity NPC156432
0.9383 High Similarity NPC472449
0.9383 High Similarity NPC37870
0.9379 High Similarity NPC189473
0.9379 High Similarity NPC23298
0.9375 High Similarity NPC278427
0.9321 High Similarity NPC239752
0.9321 High Similarity NPC275780
0.9321 High Similarity NPC472450
0.9264 High Similarity NPC39091
0.9259 High Similarity NPC207690
0.9259 High Similarity NPC146134
0.9255 High Similarity NPC259456
0.9245 High Similarity NPC471985
0.9245 High Similarity NPC276444
0.9202 High Similarity NPC303174
0.9198 High Similarity NPC261470
0.9198 High Similarity NPC229632
0.9198 High Similarity NPC329760
0.9198 High Similarity NPC25152
0.9193 High Similarity NPC471973
0.9193 High Similarity NPC204290
0.9193 High Similarity NPC139036
0.9187 High Similarity NPC476630
0.9187 High Similarity NPC218871
0.9162 High Similarity NPC227906
0.9152 High Similarity NPC188079
0.9146 High Similarity NPC170245
0.9146 High Similarity NPC43319
0.9146 High Similarity NPC272502
0.9141 High Similarity NPC186686
0.9141 High Similarity NPC306321
0.9141 High Similarity NPC270837
0.9141 High Similarity NPC236521
0.9141 High Similarity NPC152659
0.9141 High Similarity NPC248638
0.9141 High Similarity NPC303460
0.9136 High Similarity NPC29876
0.9136 High Similarity NPC167678
0.9136 High Similarity NPC40037
0.9136 High Similarity NPC61010
0.913 High Similarity NPC474290
0.913 High Similarity NPC100123
0.913 High Similarity NPC197856
0.913 High Similarity NPC280680
0.9119 High Similarity NPC170492
0.9096 High Similarity NPC472276
0.9091 High Similarity NPC218226
0.9091 High Similarity NPC476306
0.9085 High Similarity NPC326520
0.9085 High Similarity NPC50960
0.908 High Similarity NPC78332
0.908 High Similarity NPC52204
0.908 High Similarity NPC294965
0.908 High Similarity NPC474162
0.908 High Similarity NPC474150
0.908 High Similarity NPC472402
0.908 High Similarity NPC83922
0.908 High Similarity NPC194427
0.908 High Similarity NPC206605
0.908 High Similarity NPC472448
0.9074 High Similarity NPC476980
0.9074 High Similarity NPC14353
0.9074 High Similarity NPC228785
0.9074 High Similarity NPC200746
0.9074 High Similarity NPC320359
0.9074 High Similarity NPC80375
0.9074 High Similarity NPC56085
0.9074 High Similarity NPC476280
0.9068 High Similarity NPC136674
0.9062 High Similarity NPC166054
0.9062 High Similarity NPC55662
0.9036 High Similarity NPC165456
0.903 High Similarity NPC472452
0.903 High Similarity NPC120593
0.9024 High Similarity NPC475985
0.9024 High Similarity NPC236132
0.9024 High Similarity NPC220313
0.9024 High Similarity NPC12461
0.9018 High Similarity NPC66288
0.9018 High Similarity NPC40491
0.9018 High Similarity NPC278052
0.9018 High Similarity NPC198829
0.9012 High Similarity NPC476242
0.9012 High Similarity NPC46736
0.9012 High Similarity NPC74178
0.9012 High Similarity NPC184755
0.9006 High Similarity NPC68093
0.9006 High Similarity NPC142339
0.9006 High Similarity NPC274730
0.9006 High Similarity NPC191146
0.8994 High Similarity NPC216307
0.8988 High Similarity NPC310794
0.8976 High Similarity NPC477154
0.8976 High Similarity NPC6588
0.8976 High Similarity NPC117854
0.897 High Similarity NPC130920
0.897 High Similarity NPC85057
0.897 High Similarity NPC293319
0.8963 High Similarity NPC81679
0.8957 High Similarity NPC472624
0.8957 High Similarity NPC188433
0.8957 High Similarity NPC297212
0.8957 High Similarity NPC118256
0.8957 High Similarity NPC192686
0.8957 High Similarity NPC36217
0.8957 High Similarity NPC119224
0.8957 High Similarity NPC119209
0.8957 High Similarity NPC235018
0.8957 High Similarity NPC45146
0.8957 High Similarity NPC328102
0.8957 High Similarity NPC474960
0.8951 High Similarity NPC78225
0.8951 High Similarity NPC217677
0.8951 High Similarity NPC237418
0.8951 High Similarity NPC273843
0.8951 High Similarity NPC218313
0.8951 High Similarity NPC241904
0.8951 High Similarity NPC476981
0.8951 High Similarity NPC236796
0.8951 High Similarity NPC300727
0.8951 High Similarity NPC165977
0.8951 High Similarity NPC474681
0.8944 High Similarity NPC200246
0.8944 High Similarity NPC472280
0.8944 High Similarity NPC234255
0.8938 High Similarity NPC237994
0.8938 High Similarity NPC471982
0.8938 High Similarity NPC249570
0.8931 High Similarity NPC88804
0.8931 High Similarity NPC3825
0.8929 High Similarity NPC223375
0.8929 High Similarity NPC475825
0.8929 High Similarity NPC4200
0.8922 High Similarity NPC288813
0.8922 High Similarity NPC177480
0.8916 High Similarity NPC173292
0.8916 High Similarity NPC235610
0.8909 High Similarity NPC7483
0.8909 High Similarity NPC273959
0.8902 High Similarity NPC32694
0.8902 High Similarity NPC258331
0.8902 High Similarity NPC234644
0.8902 High Similarity NPC474038
0.8902 High Similarity NPC472906
0.8902 High Similarity NPC266314
0.8902 High Similarity NPC474187
0.8902 High Similarity NPC57715
0.8896 High Similarity NPC204879
0.8896 High Similarity NPC469658
0.8896 High Similarity NPC235448
0.8895 High Similarity NPC150977
0.8889 High Similarity NPC470600
0.8889 High Similarity NPC472455
0.8889 High Similarity NPC282307
0.8889 High Similarity NPC170026
0.8889 High Similarity NPC472907
0.8889 High Similarity NPC475799
0.8889 High Similarity NPC474167
0.8889 High Similarity NPC133970
0.8889 High Similarity NPC5322
0.8889 High Similarity NPC138243
0.8889 High Similarity NPC13779
0.8889 High Similarity NPC6633
0.8889 High Similarity NPC470762
0.8882 High Similarity NPC255350
0.8882 High Similarity NPC22519
0.8882 High Similarity NPC472905
0.8882 High Similarity NPC183878
0.8882 High Similarity NPC145379
0.8882 High Similarity NPC95842
0.8882 High Similarity NPC178964
0.8882 High Similarity NPC280530
0.8882 High Similarity NPC69394
0.8882 High Similarity NPC231018
0.8882 High Similarity NPC274327
0.8882 High Similarity NPC47781
0.8882 High Similarity NPC89474
0.8882 High Similarity NPC176775
0.8882 High Similarity NPC160951
0.8882 High Similarity NPC476631
0.8875 High Similarity NPC154345
0.8862 High Similarity NPC150131
0.8862 High Similarity NPC8965
0.8862 High Similarity NPC474024
0.8855 High Similarity NPC259757
0.8855 High Similarity NPC473286
0.8855 High Similarity NPC25361
0.8848 High Similarity NPC8300
0.8848 High Similarity NPC472635
0.8848 High Similarity NPC201800
0.8848 High Similarity NPC470694
0.8844 High Similarity NPC476170
0.8841 High Similarity NPC161947
0.8841 High Similarity NPC475886
0.8841 High Similarity NPC155302
0.8841 High Similarity NPC475784

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475805 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8882 High Similarity NPD2801 Approved
0.865 High Similarity NPD2393 Clinical (unspecified phase)
0.8614 High Similarity NPD5494 Approved
0.8589 High Similarity NPD1934 Approved
0.8553 High Similarity NPD1511 Approved
0.8447 Intermediate Similarity NPD1512 Approved
0.8434 Intermediate Similarity NPD3882 Suspended
0.8412 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8412 Intermediate Similarity NPD6166 Phase 2
0.8412 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8363 Intermediate Similarity NPD7473 Discontinued
0.8314 Intermediate Similarity NPD3818 Discontinued
0.8294 Intermediate Similarity NPD6232 Discontinued
0.8272 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8266 Intermediate Similarity NPD7054 Approved
0.8266 Intermediate Similarity NPD5844 Phase 1
0.8235 Intermediate Similarity NPD6959 Discontinued
0.8218 Intermediate Similarity NPD7074 Phase 3
0.8218 Intermediate Similarity NPD7472 Approved
0.816 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8155 Intermediate Similarity NPD3817 Phase 2
0.8133 Intermediate Similarity NPD4380 Phase 2
0.8095 Intermediate Similarity NPD1465 Phase 2
0.8079 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8068 Intermediate Similarity NPD6797 Phase 2
0.8023 Intermediate Similarity NPD7251 Discontinued
0.7988 Intermediate Similarity NPD7819 Suspended
0.7978 Intermediate Similarity NPD7808 Phase 3
0.7963 Intermediate Similarity NPD2800 Approved
0.7941 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD1247 Approved
0.7914 Intermediate Similarity NPD3750 Approved
0.7912 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD3749 Approved
0.7849 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD7075 Discontinued
0.7831 Intermediate Similarity NPD2532 Approved
0.7831 Intermediate Similarity NPD2534 Approved
0.7831 Intermediate Similarity NPD2533 Approved
0.7824 Intermediate Similarity NPD6801 Discontinued
0.7791 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD5402 Approved
0.773 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD6559 Discontinued
0.7716 Intermediate Similarity NPD1510 Phase 2
0.7701 Intermediate Similarity NPD6234 Discontinued
0.7701 Intermediate Similarity NPD919 Approved
0.7683 Intermediate Similarity NPD1549 Phase 2
0.7669 Intermediate Similarity NPD2796 Approved
0.7665 Intermediate Similarity NPD7390 Discontinued
0.7661 Intermediate Similarity NPD7411 Suspended
0.765 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD3926 Phase 2
0.7614 Intermediate Similarity NPD7199 Phase 2
0.7607 Intermediate Similarity NPD3748 Approved
0.7602 Intermediate Similarity NPD6599 Discontinued
0.7598 Intermediate Similarity NPD7228 Approved
0.7593 Intermediate Similarity NPD1607 Approved
0.7584 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD943 Approved
0.7578 Intermediate Similarity NPD1240 Approved
0.7569 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD2935 Discontinued
0.7561 Intermediate Similarity NPD6099 Approved
0.7561 Intermediate Similarity NPD6100 Approved
0.756 Intermediate Similarity NPD6799 Approved
0.7544 Intermediate Similarity NPD3226 Approved
0.7528 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD37 Approved
0.75 Intermediate Similarity NPD3751 Discontinued
0.75 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD4965 Approved
0.7486 Intermediate Similarity NPD4966 Approved
0.7486 Intermediate Similarity NPD4967 Phase 2
0.7486 Intermediate Similarity NPD7768 Phase 2
0.7438 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD920 Approved
0.7427 Intermediate Similarity NPD5403 Approved
0.7425 Intermediate Similarity NPD1243 Approved
0.7419 Intermediate Similarity NPD8434 Phase 2
0.7419 Intermediate Similarity NPD8150 Discontinued
0.741 Intermediate Similarity NPD2346 Discontinued
0.7394 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD6651 Approved
0.7375 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD3787 Discontinued
0.7358 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD6777 Approved
0.7358 Intermediate Similarity NPD6778 Approved
0.7358 Intermediate Similarity NPD6776 Approved
0.7358 Intermediate Similarity NPD6779 Approved
0.7358 Intermediate Similarity NPD6782 Approved
0.7358 Intermediate Similarity NPD6781 Approved
0.7358 Intermediate Similarity NPD6780 Approved
0.7351 Intermediate Similarity NPD8312 Approved
0.7351 Intermediate Similarity NPD8313 Approved
0.731 Intermediate Similarity NPD5401 Approved
0.731 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD2344 Approved
0.7289 Intermediate Similarity NPD2799 Discontinued
0.7284 Intermediate Similarity NPD4625 Phase 3
0.7278 Intermediate Similarity NPD5711 Approved
0.7278 Intermediate Similarity NPD5710 Approved
0.7256 Intermediate Similarity NPD1613 Approved
0.7256 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7245 Intermediate Similarity NPD7435 Discontinued
0.7219 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD447 Suspended
0.7209 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD2403 Approved
0.7193 Intermediate Similarity NPD3300 Phase 2
0.7193 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7182 Intermediate Similarity NPD7229 Phase 3
0.7178 Intermediate Similarity NPD3027 Phase 3
0.7176 Intermediate Similarity NPD4628 Phase 3
0.7164 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7164 Intermediate Similarity NPD7783 Phase 2
0.7157 Intermediate Similarity NPD7697 Approved
0.7157 Intermediate Similarity NPD7698 Approved
0.7157 Intermediate Similarity NPD7696 Phase 3
0.7151 Intermediate Similarity NPD7685 Pre-registration
0.7151 Intermediate Similarity NPD7240 Approved
0.7143 Intermediate Similarity NPD1551 Phase 2
0.7135 Intermediate Similarity NPD2309 Approved
0.7134 Intermediate Similarity NPD2313 Discontinued
0.7134 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD7871 Phase 2
0.7121 Intermediate Similarity NPD7870 Phase 2
0.7108 Intermediate Similarity NPD230 Phase 1
0.7107 Intermediate Similarity NPD6823 Phase 2
0.71 Intermediate Similarity NPD7701 Phase 2
0.7098 Intermediate Similarity NPD6534 Approved
0.7098 Intermediate Similarity NPD6535 Approved
0.7098 Intermediate Similarity NPD4360 Phase 2
0.7098 Intermediate Similarity NPD4363 Phase 3
0.7087 Intermediate Similarity NPD4665 Approved
0.7087 Intermediate Similarity NPD4111 Phase 1
0.7086 Intermediate Similarity NPD1653 Approved
0.7081 Intermediate Similarity NPD7286 Phase 2
0.7079 Intermediate Similarity NPD7801 Approved
0.7065 Intermediate Similarity NPD8151 Discontinued
0.7062 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD4361 Phase 2
0.7045 Intermediate Similarity NPD7458 Discontinued
0.7045 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD5406 Approved
0.7041 Intermediate Similarity NPD5404 Approved
0.7041 Intermediate Similarity NPD5405 Approved
0.7041 Intermediate Similarity NPD5408 Approved
0.7039 Intermediate Similarity NPD4288 Approved
0.703 Intermediate Similarity NPD3268 Approved
0.703 Intermediate Similarity NPD7874 Approved
0.703 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD7549 Discontinued
0.7019 Intermediate Similarity NPD4749 Approved
0.7019 Intermediate Similarity NPD7907 Approved
0.7012 Intermediate Similarity NPD4908 Phase 1
0.7011 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD7028 Phase 2
0.7005 Intermediate Similarity NPD5953 Discontinued
0.7 Intermediate Similarity NPD1201 Approved
0.7 Intermediate Similarity NPD1471 Phase 3
0.6994 Remote Similarity NPD2798 Approved
0.699 Remote Similarity NPD7699 Phase 2
0.699 Remote Similarity NPD7700 Phase 2
0.6979 Remote Similarity NPD4287 Approved
0.6977 Remote Similarity NPD8166 Discontinued
0.6977 Remote Similarity NPD7003 Approved
0.6975 Remote Similarity NPD6696 Suspended
0.697 Remote Similarity NPD2494 Approved
0.697 Remote Similarity NPD2493 Approved
0.695 Remote Similarity NPD4583 Approved
0.695 Remote Similarity NPD4582 Approved
0.6947 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6946 Remote Similarity NPD4060 Phase 1
0.694 Remote Similarity NPD8127 Discontinued
0.6939 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6936 Remote Similarity NPD6190 Approved
0.6933 Remote Similarity NPD2797 Approved
0.6933 Remote Similarity NPD1470 Approved
0.6928 Remote Similarity NPD3764 Approved
0.6928 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6914 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6905 Remote Similarity NPD5124 Phase 1
0.6905 Remote Similarity NPD1933 Approved
0.6905 Remote Similarity NPD5123 Clinical (unspecified phase)
0.69 Remote Similarity NPD4004 Approved
0.69 Remote Similarity NPD4002 Approved
0.6889 Remote Similarity NPD5761 Phase 2
0.6889 Remote Similarity NPD5760 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data